These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20878084)

  • 1. Identification of an intermediate signature that marks the initial phases of the colorectal adenoma-carcinoma transition.
    Tang H; Guo Q; Zhang C; Zhu J; Yang H; Zou YL; Yan Y; Hong D; Sou T; Yan XM
    Int J Mol Med; 2010 Nov; 26(5):631-41. PubMed ID: 20878084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced expression of microenvironmental Th1 cytokines accompanies adenomas-carcinomas sequence of colorectum.
    Cui G; Goll R; Olsen T; Steigen SE; Husebekk A; Vonen B; Florholmen J
    Cancer Immunol Immunother; 2007 Jul; 56(7):985-95. PubMed ID: 17160410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ELR+ CXC chemokine expression in benign and malignant colorectal conditions.
    Rubie C; Frick VO; Wagner M; Schuld J; Gräber S; Brittner B; Bohle RM; Schilling MK
    BMC Cancer; 2008 Jun; 8():178. PubMed ID: 18578857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition.
    Kalmár A; Nagy ZB; Galamb O; Csabai I; Bodor A; Wichmann B; Valcz G; Barták BK; Tulassay Z; Igaz P; Molnár B
    BMC Cancer; 2019 Nov; 19(1):1059. PubMed ID: 31694571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered miR-21, miRNA-148a Expression in Relation to KRAS Mutation Status as Indicator of Adenoma-Carcinoma Transitional Pattern in Colorectal Adenoma and Carcinoma Lesions.
    Igder S; Mohammadiasl J; Mokarram P
    Biochem Genet; 2019 Dec; 57(6):767-780. PubMed ID: 30997628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A gene expression and pre-mRNA splicing signature that marks the adenoma-adenocarcinoma progression in colorectal cancer.
    Pesson M; Volant A; Uguen A; Trillet K; De La Grange P; Aubry M; Daoulas M; Robaszkiewicz M; Le Gac G; Morel A; Simon B; Corcos L
    PLoS One; 2014; 9(2):e87761. PubMed ID: 24516561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of p-STAT3 expression in human colorectal adenocarcinoma.
    Park JK; Hong R; Kim KJ; Lee TB; Lim SC
    Oncol Rep; 2008 Sep; 20(3):597-604. PubMed ID: 18695911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consensus molecular subtype classification of colorectal adenomas.
    Komor MA; Bosch LJ; Bounova G; Bolijn AS; Delis-van Diemen PM; Rausch C; Hoogstrate Y; Stubbs AP; de Jong M; Jenster G; van Grieken NC; Carvalho B; Wessels LF; Jimenez CR; Fijneman RJ; Meijer GA;
    J Pathol; 2018 Nov; 246(3):266-276. PubMed ID: 29968252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of disrupted pathways in ulcerative colitis-related colorectal carcinoma by systematic tracking the dysregulated modules.
    Wu D; Li Q; Song G; Lu J
    J BUON; 2016; 21(2):366-74. PubMed ID: 27273946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas.
    Gattolliat CH; Uguen A; Pesson M; Trillet K; Simon B; Doucet L; Robaszkiewicz M; Corcos L
    Eur J Cancer; 2015 Feb; 51(3):409-20. PubMed ID: 25586944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CBX2 Expression in Colorectal Mucosa-adenoma-adenocarcinoma Sequence.
    Wang B; Huang M; Wang X; Tseng Y; Luo F; Liu J
    J Coll Physicians Surg Pak; 2021 Sep; 31(9):1051-1056. PubMed ID: 34500520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
    Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
    BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MMP3 and CXCL1 are potent stromal protein markers of dysplasia-carcinoma transition in sporadic colorectal cancer.
    Sipos F; Germann TM; Wichmann B; Galamb O; Spisák S; Krenács T; Tulassay Z; Molnár B; Műzes G
    Eur J Cancer Prev; 2014 Sep; 23(5):336-43. PubMed ID: 24999605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragile histidine triad (FHIT) gene is overexpressed in colorectal cancer.
    Wierzbicki PM; Adrych K; Kartanowicz D; Dobrowolski S; Stanislawowski M; Chybicki J; Godlewski J; Korybalski B; Smoczynski M; Kmiec Z
    J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():63-70. PubMed ID: 20083853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene-dosage dependent overexpression at the 13q amplicon identifies DIS3 as candidate oncogene in colorectal cancer progression.
    de Groen FL; Krijgsman O; Tijssen M; Vriend LE; Ylstra B; Hooijberg E; Meijer GA; Steenbergen RD; Carvalho B
    Genes Chromosomes Cancer; 2014 Apr; 53(4):339-48. PubMed ID: 24478024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression.
    Komor MA; de Wit M; van den Berg J; Martens de Kemp SR; Delis-van Diemen PM; Bolijn AS; Tijssen M; Schelfhorst T; Piersma SR; Chiasserini D; Sanders J; Rausch C; Hoogstrate Y; Stubbs AP; de Jong M; Jenster G; Carvalho B; Meijer GA; Jimenez CR; Fijneman RJA;
    Int J Cancer; 2020 Apr; 146(7):1979-1992. PubMed ID: 31411736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct changes of dendritic cell number and IL-12 mRNA level in adjacent mucosa throughout the colorectal adenoma-carcinoma sequence.
    Cui G; Yuan A; Goll R; Olsen T; Husebekk A; Vonen B; Florholmen J
    Cancer Immunol Immunother; 2007 Dec; 56(12):1993-2001. PubMed ID: 17579859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-17A in the tumor microenvironment of the human colorectal adenoma-carcinoma sequence.
    Cui G; Yuan A; Goll R; Florholmen J
    Scand J Gastroenterol; 2012 Nov; 47(11):1304-12. PubMed ID: 22989213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential CXC receptor expression in colorectal carcinomas.
    Rubie C; Kollmar O; Frick VO; Wagner M; Brittner B; Gräber S; Schilling MK
    Scand J Immunol; 2008 Dec; 68(6):635-44. PubMed ID: 18959627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.